'Capital market-related stocks already discount couple of years of growth'

The margin of safety in capital market stocks for near-term investors is limited

image
Market News: Valuations of capital market-related stocks are no longer inexpensive, says Sachin Shah of Emkay Investment Managers
Nikita Vashisht New Delhi
4 min read Last Updated : Jul 15 2025 | 10:35 PM IST
As the markets prepare for India Inc. to unveil its earnings for the June quarter, SACHIN SHAH, executive director and fund manager at Emkay Investment Managers, tells Nikita Vashisht in an email interview that the markets are likely to stay range-bound until early results and management commentaries provide clearer guidance on business outlook. Clarity on both fronts—tariffs and earnings, he said, could act as catalysts for the next leg of the market move. Edited excerpts:
 
What is your reading of the current market scenario? How long will this consolidation phase last?
Market consolidation could be a function of some profit booking after a sharp rally. That said, the broader macroeconomic environment remains highly supportive of a continued rebound in India’s economic growth.
 
Key positives include easing interest rates, improved systemic liquidity, robust monsoon season, moderating crude oil prices, and strengthening geopolitical tailwinds favouring India.
 
To my mind, the only uncertainty in the immediate future appears to be the one around the final tariff structure to be announced by the US—not just for India, but globally. India’s relative positioning within this framework could influence foreign investor (FII) sentiment and trade dynamics.
 
Additionally, with the corporate earnings season kicking off, markets are likely to stay range-bound until early results and management commentaries provide clearer guidance on business outlook. Clarity on both fronts—tariffs and earnings, could act as catalysts for the next leg of the market move.  Track Stock Market LIVE Updates
 
Which sectors look oversold/overbought and are ripe for profit booking/rebound as things stand?
From a two–five year perspective, we are optimistic about the outlook for private banking, auto & auto-ancillaries, pharma (CDMO / CRAMs) and discretionary consumption. Even the information technology (IT) sector, while it faces short-term growth headwinds, offers reasonable valuations and a good probability of a rebound.
 
Do you think the rally in the capital market–related stocks has run its course?
While valuations in capital market-related businesses are no longer inexpensive, the structural shift underway in India's savings behaviour is both real and transformative. We are witnessing an unprecedented reallocation of household savings from traditional fixed income products to equities—a trend that has fundamentally altered the landscape for capital market players. This shift is being appropriately reflected in the valuations of related businesses.
 
However, it's important to note that in many cases, current prices already discount the next couple of years of growth. As a result, the margin of safety for near-term investors is limited. That said, for long-term investors with a 7–10 year horizon, this sector still holds significant potential.
 
The financialisation of savings in India is likely to become even more broad-based in the years ahead, creating a favourable backdrop for capital market businesses to grow sustainably and compound return.  ALSO READ: Anthem Biosciences' ₹3,395-cr IPO opens today: GMP at 17%, should you bid?
 
Do you think Trump's tariff policies will keep upside down in check in pharma, auto, and metal sectors?
The real impact will depend on two factors: the relative tariff treatment of India versus other countries, and the value proposition Indian manufacturers offer globally. While there is some nervousness around potential disruptions, we're not overly concerned at this stage.
 
Over the years, Indian manufacturers have demonstrated strong competitiveness, and in many cases, a clear "right to win" on the global stage. Sectors such as Specialty Chemicals, Pharmaceuticals (CDMO, CRAMs, generic formulations), Auto Components, Engineering (including power equipment), Textiles, and more recently Electronics Manufacturing, have built domain expertise, achieved supply-side scale, and shown consistent respect for global IP norms.
 
Even if tariffs are introduced or revised, companies that offer high-quality, cost-efficient, and scalable solutions are likely to retain or even grow their share in global markets. So while short-term volatility cannot be ruled out, the medium- to long-term outlook remains positive for these sectors.
 
Monthly SIP inflow touched a record high in June 2025. What has been your strategy in recent months?
Our strategy has remained consistent: focus on high-quality management teams leading structurally profitable businesses, and invest in them at reasonable valuations. However, the most important principle, especially in a market like this, is to stay invested.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Market InterviewsMarketsInvestment tipsMarket OutlookTrump tariffsMarkets insightsIndian stock markets

Next Story